(Q24246358)

inferred from title

author

Nicolette C Notermans

5

object named as

Nicolette C Notermans

0 references

Alexander F J E Vrancken

1

object named as

Alexander FJE Vrancken

0 references

John H. J. Wokke

4

object named as

John HJ Wokke

0 references

author name string

Richard AC Hughes

2

0 references

Gérard Said

Cochrane Database of Systematic Reviews

3

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

Nonsystemic vasculitic neuropathy: insights from a clinical cohort

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Vasculitis confined to peripheral nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Nonsystemic vasculitic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

The clinical spectrum of inflammatory-angiopathic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Vasculitic neuropathy. A clinical and pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Clinicopathologic study of 43 patients with sural nerve vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Necrotizing lymphocytic vasculitis limited to the peripheral nerves: report of six cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Progressive idiopathic axonal neuropathy--a comparative clinical and histopathological study with vasculitic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Vasculitic neuropathy--electrodiagnostic findings and association with malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Microscopic polyangiitis and polyarteritis nodosa: how and when do they start?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Plasmapheresis for rheumatic diseases in the twenty-first century: take it or leave it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

A comparison of statistical methods for meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Peripheral neuropathy in Wegener's granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Rituximab in cryoglobulinemic peripheral neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Advances in the use of biologic agents for the treatment of systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Standardized neurologic evaluations of 128 patients with Wegener granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Vasculitides associated with malignancies: analysis of sixty patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Long-term follow-up study of periarteritis nodosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Vulnerability of nerve fibres to ischaemia. A quantitative light and electron microscope study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Magnetic resonance imaging of skeletal muscle involvement in limb restricted vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Therapy for vasculitic neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Clinimetric properties of a walking scale in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

P-ANCA vasculitic neuropathy with 12-year latency between onset of neuropathy and systemic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Indication for plasma exchange for systemic necrotizing vasculidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Clinicopathological features of Churg-Strauss syndrome-associated neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

21 January 2018

Single-organ vasculitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

The role of IVIg in autoimmune neuropathies: the latest evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Challenges in the management of microscopic polyangiitis: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

21 January 2018

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

The last classification of vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Muscular polyarteritis nodosa as a cause of fever of undetermined origin: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Mycophenolate mofetil in low doses stabilizes and improves antineutrophil cytoplasmic antibody-associated vasculitis and lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Vasculitis restricted to the lower limbs: a clinical and histopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

How can relapses be detected and prevented in primary systemic small-vessel vasculitides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Immunosuppressive and corticosteroid therapy of polyarteritis nodosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Response of vasculitic peripheral neuropathy to intravenous immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Biopsy diagnosis of systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Advances in immunosuppressive drug therapy for use in autoimmune disease and systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Connecting impairment, disability, and handicap in immune mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Getting closer to patients: the INCAT Overall Disability Sum Score relates better to patients' own clinical judgement in immune-mediated polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

EULAR recommendations for the management of large vessel vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

EULAR recommendations for the management of primary small and medium vessel vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Polyarteritis nodosa limited to calf muscles: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Diagnostic usefulness and limitations of the sural nerve biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Paraneoplastic vasculitis of the peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Peripheral neuropathy in systemic vasculitides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Polyneuropathy and systemic vasculitis. An electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Improving therapeutic options for patients with giant cell arteritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Localized versus systemic vasculitis: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Conduction block in neuropathies with necrotizing vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Neuromuscular complications of connective tissue diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Primary and secondary vasculitic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

21 January 2018

Infectious neuropathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

An update on the classification and treatment of vasculitic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Polyarteritis nodosa when applying the Chapel Hill nomenclature--a descriptive study on ten patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

A review of randomized controlled trials using therapeutic apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Tumor necrosis factor-alpha antagonists and neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Nonsystemic vasculitic neuropathy presenting with truncal segmental sensory disturbance and hyperhidrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Advanced methods in meta-analysis: multivariate approach and meta-regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Interventions for renal vasculitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Etanercept plus standard therapy for Wegener's granulomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

Clinical Characteristics and Prognosis of Vasculitic Mononeuropathy Multiplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Skin denervation in vasculitic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

The clinical spectrum of necrotizing angiopathy of the peripheral nervous system

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

The peripheral neuropathy of necrotizing arteritis: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Treatment of Churg-Strauss syndrome without poor-prognosis factors: A multicenter, prospective, randomized, open-label study of seventy-two patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Sensory-predominant, painful, idiopathic neuropathy: inflammatory changes in sural nerves

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Peripheral neuropathy associated with leflunomide: is there a risk patient profile?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

"Pseudo-conduction block" in vasculitic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Cutaneous polyarteritis nodosa: revisiting its definition and diagnostic criteria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Non-systemic vasculitic neuropathy presenting with a painful polyradiculopathy: a case report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: a comparative study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Skeletal muscle vasculitis exclusive of inflammatory myopathic conditions: a clinicopathologic study of 40 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

[Diagnosis and therapy of vasculitic neuropathy. Consensus statement of the German Centers for Neuromuscular Disease]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

No additional steroid-sparing effect of cyclosporine A in giant cell arteritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Damage occurs early in systemic vasculitis and is an index of outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Acute necrotizing vasculitis (polyarteritis nodosa?) confined to the nerve with spontaneous recovery

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Polyarteritis nodosa and Churg-Strauss angiitis: characteristics and outcome in 38 patients over 65 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Vasculitis of the nervous system

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Diagnostic value of nerve and muscle biopsy in suspected vasculitis cases.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Localized Striated Muscle Vasculitis in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Drug-induced vasculitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Effect of leflunomide on the peripheral nerves in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

The additional yield of combined nerve/muscle biopsy in vasculitic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

[Intravenous therapy with methylprednisolone and cyclophosphamide in vasculitis of peripheral nervous system. Evaluation of 8 patients]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021

Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006050.PUB2

7 January 2021